Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
Titel:
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
Auteur:
Reiman, T. Lai, R. Veillard, A.S. Paris, E. Soria, J.C. Rosell, R. Taron, M. Graziano, S. Kratzke, R. Seymour, L. Shepherd, F.A. Pignon, J.P. Sève, P.